LY6E and pancreatic neoplasm: The mRNA expression data across multiple studies shows that ovarian, colorectal, gastric, breast, lung, brain and CNS, cervical, esophageal, head and neck and pancreatic cancers express significant high levels of Ly6D, Ly6E, Ly6H, Ly6K.